A recent report revealed that administration of RRx‐001, an anti‐CD47‐SIRPα small molecule with vascular normalizing properties, prior to temozolomide or irinotecan results in increased drug uptake in orthotropic glioma tumors.91 This evidence concerns the gene CD47 and glioma.